Tag: Patient Safety

FDA: Class I recall of Arrow central venous access and catheter kits

Editor's Note The Food and Drug Administration (FDA) on December 16 identified the recall by Teleflex and Arrow International, LLC, of its Arrow MAC Two-Lumen Central Venous Access Kits and Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen Central Venous Catheter (CVC) Kits as Class I, the most serious. The recall…

Read More

By: Judy Mathias
January 4, 2023
Share

Utility of lighted magnification, borescopes to inspect flexible endoscopes

Editor's Note This study led by epidemiologist Cori L. Ofstead, MSPH, and associates, St Paul, Minnesota, found visible damage and residue or debris in 100% of 25 processed flexible endoscopes, using a new visual inspection program that included magnification and borescopes. Fully processed endoscopes were examined twice during a 2-month…

Read More

By: Judy Mathias
January 3, 2023
Share

FDA: Class I recall of Arrow AutoCAT2, AC3 IABPs

Editor's Note The Food and Drug Administration (FDA), on December 20, identified the recall by Arrow International, LLC, subsidiary of Teleflex, Inc, of its Arrow AutoCAT 2 and AC3 intra-aortic balloon pumps (IABPs) as Class I, the most serious. IABPs are used in patients having cardiac and non-cardiac surgery, and…

Read More

By: Judy Mathias
January 3, 2023
Share

Deloitte surveys 2023 outlook for healthcare systems, plans

Editor's Note Hospital leaders are preparing for what is expected to be a turbulent 2023, according to results of a December 13 survey from the Deloitte Center for Health Solutions, reports December 19 Healthcare Purchasing News. The majority of health system leaders said that staffing challenges (85%) and inflation (76%)…

Read More

By: Bridget Brown
December 29, 2022
Share

1-year mortality after major surgery in older adults

Editor's Note In this study, researchers from Yale School of Medicine, New Haven, Connecticut, find that mortality after major surgery is elevated in older adults who are frail or who have probable dementia. A total of 1,193 major surgical procedures in 992 Medicare beneficiaries were analyzed. Among the findings: Overall,…

Read More

By: Judy Mathias
December 12, 2022
Share

FDA: Exela Pharma Sciences, LLC, expands recall of Sodium Bicarb

Editor's Note The Food and Drug Administration (FDA) on November 29 posted Exela Pharma Sciences’ expansion of its recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton. The product poses a safety concern because of vial breakage with flying glass when pressurized while preparing the product for…

Read More

By: Judy Mathias
December 12, 2022
Share

Study links molecular changes to long COVID

Editor's Note This study by researchers from the Icahn School of Medicine at Mount Sinai, New York City, is one of the first to link long COVID symptoms at more than 1 year with changes in gene expression that occurred during the acute stage of COVID-19. The researchers examined blood…

Read More

By: Judy Mathias
December 12, 2022
Share

FDA: Class I recall of Thermo Scientific Gram Negative IVD AST Sensititre Plate

Editor's Note The Food and Drug Administration (FDA) on December 9 identified the recall by Remel, Inc, of its Thermo Scientific Gram Negative IVD AST Sensititre Plate as Class I, the most serious. The Plates are used to test the susceptibility of Gram-negative bacterial infections to specific antibiotics. The recall…

Read More

By: Judy Mathias
December 12, 2022
Share

FDA: Class I recall of Dewei Medical Equipment’s DNA/RNA Preservation Kits

Editor's Note The Food and Drug Administration (FDA) on December 8 identified the recall by Dewei Medical Equipment Co of its DNA/RNA Preservation Kits as Class I, the most serious. The kits are used to collect, preserve, and transport clinical samples that will be tested for viruses, including COVID-19. The…

Read More

By: Judy Mathias
December 8, 2022
Share

Bypassing PACU after hip, knee arthroplasties

Editor's Note This prospective Danish study finds that transfer to a postanesthesia care unit (PACU) immediately after elective hip and knee arthroplasty might be unnecessary in low-risk patients. A total of 696 total knee (274), total hip (287), and unicompartmental knee (135) arthroplasty patients were analyzed. Of those, 307 bypassed…

Read More

By: Judy Mathias
December 7, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat